Rexahn
is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read moreRexahn
is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
News
Apr 01, 2025
Owler
Ocuphire Pharma, Inc.: Rexahn's employee count changed from 14 in Dec 2023 to 18 in Dec 2024
Nov 06, 2020
StreetInsider
Press Release: Rexahn : Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
Nov 05, 2020
Baltimore Citybizlist
Rexahn: Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split
Nov 05, 2020
Benzinga
Rexahn: Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split and Merger Transaction with Ocuphire Pharma
Nov 05, 2020
GlobeNewswire
Press Release: Rexahn : Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split and Merger Transaction with Ocuphire Pharma
Jul 08, 2020
centralcharts
Press Release: Rexahn : SHAREHOLDER ALERT: WeissLaw LLP Reminds REXN and DLMV Shareholders About Its Ongoing Investigations
Jul 08, 2020
centralcharts
Press Release: Rexahn : INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Rexahn Pharmaceuticals, Inc.- REXN
Jul 01, 2020
Acrofan
Rexahn: REXAHN PARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Rexahn Pharmaceuticals
Jul 01, 2020
centralcharts
Press Release: Rexahn : REXAHN PARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Rexahn Pharmaceuticals, Inc. - REXN
Jun 24, 2020
Crain's Detroit Business
Rexahn: Farmington Hills biotech company Ocuphire strikes deal that will put it on stock exchange
Rexahn Competitors
1
2
3
4
5
6
7
8
9
10